Brainstorm Cell Therapeutics Overview
Brainstorm Cell Therapeutics Discounted Cash Flow
DCF Analysis for BCLI.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.02
Current Fair Value
$-0.02
↓ 102.4% Downside
Overvalued by 102.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison